Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
Clinical trial NCT03461627 · UNKNOWN
Trial details
- NCT number
- NCT03461627
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2018-10-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.